76 related articles for article (PubMed ID: 30109501)
1. Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma.
Zhu F; Wu Y; Wang H
Front Oncol; 2023; 13():1259331. PubMed ID: 37860184
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N; Sarı M; Kahvecioglu FA; Ozcan E; Akdag MO; Dogan A; Yıldırım S; Sonusen SD; Yunusov E; Yasar A; Celebi A; Sever N; Kocaaslan E; Erel P; Agyol Y; Guren AK; Arıkan R; Isık S; Balvan O; Geredelı C; Uygun K; Hacibekiroglu I; Kostek O; Bayoglu IV
Oncol Res Treat; 2024 Apr; ():1-7. PubMed ID: 38565096
[TBL] [Abstract][Full Text] [Related]
3. Association of Socioeconomic Disparities With Nasopharyngeal Carcinoma Survival in an Endemic Area, China.
Meng DF; Zhang HB; Liu GY; Peng LX; Yang Q; Liu ZH; Tian R; Ma J; Fu L
Cancer Control; 2023; 30():10732748231188261. PubMed ID: 37523422
[TBL] [Abstract][Full Text] [Related]
4. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.
Nie M; Sun P; Chen C; Bi X; Wang Y; Yang H; Liu P; Li Z; Xia Y; Jiang W
J Cancer; 2017; 8(5):809-815. PubMed ID: 28382143
[TBL] [Abstract][Full Text] [Related]
5. Head and Neck Cancer of Unknown Primary: A Multicenter Retrospective Cohort study in Northern Thailand, an Endemic Nasopharyngeal Cancer Area.
Sittitrai P; Ruenmarkkaew D; Chitapanarux I; Muangwong P; Kangsadarnwiroon K; Benjawongsatien R; Srivanitchapoom C; Donchalermpak S; Asakij T
Asian Pac J Cancer Prev; 2024 Feb; 25(2):699-708. PubMed ID: 38415558
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics.
Cannon T; Zanation AM; Lai V; Weissler MC
Laryngoscope; 2006 Jun; 116(6):1021-6. PubMed ID: 16735924
[TBL] [Abstract][Full Text] [Related]
7. Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma.
Ding Y; Xiao X; Zeng L; Shang Q; Jiang W; Xiong S; Duan X; Shen J; Wang R; Guo J; Pan Y
Bioact Mater; 2021 Dec; 6(12):4707-4716. PubMed ID: 34095627
[TBL] [Abstract][Full Text] [Related]
8. Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group.
de Foucher T; Hennebert C; Dabi Y; Ouldamer L; Lavoué V; Dion L; Canlorbe G; Bolze PA; Golfier F; Akladios C; Lecointre L; Kerbage Y; Collinet P; Bricou A; Carcopino X; Huchon C; Raimond E; Graesslin O; Owen C; Touboul C; Ballester M; Darai E; Bendifallah S
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33198384
[TBL] [Abstract][Full Text] [Related]
9. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
Yan P; Yin H; Guo W; Sun X; Li F; Huang S; Bian X; Wang F; Zhang F; Wang B; Zhou H; Zhou C; Yin L; Jiang X; Jiang N; Wu J; Liu J; Song D; He X
Cancer Med; 2020 Sep; 9(17):6166-6172. PubMed ID: 32657029
[TBL] [Abstract][Full Text] [Related]
10. DW-MRI-Guided Dose Escalation Improves Local Control of Locally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy.
Huang Y; Feng M; Yang X; Zhou J; Li L; Xu K; Xu G; Lang J
Cancer Manag Res; 2020; 12():3107-3116. PubMed ID: 32440209
[TBL] [Abstract][Full Text] [Related]
11. MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.
Tian Y; Tang L; Yi P; Pan Q; Han Y; Shi Y; Rao S; Tan S; Xia L; Lin J; Oyang L; Tang Y; Liang J; Luo X; Liao Q; Wang H; Zhou Y
J Cancer; 2020; 11(13):3976-3985. PubMed ID: 32328201
[TBL] [Abstract][Full Text] [Related]
12. Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma.
Ha H; Keam B; Ock CY; Kim TM; Kim JH; Chung EJ; Kwon SK; Ahn SH; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2021 Jan; 36(1):175-181. PubMed ID: 32218101
[TBL] [Abstract][Full Text] [Related]
13. Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area.
Yu Y; Liang H; Lv X; Ke L; Qiu W; Huang X; Liu G; Li W; Guo X; Xiang Y; Xia W
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2231-2243. PubMed ID: 30109501
[TBL] [Abstract][Full Text] [Related]
14. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Liu GY; Lv X; Wu YS; Mao MJ; Ye YF; Yu YH; Liang H; Yang J; Ke LR; Qiu WZ; Huang XJ; Li WZ; Guo X; Xiang YQ; Xia WX
Cancer Commun (Lond); 2018 May; 38(1):21. PubMed ID: 29764487
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
You R; Hua YJ; Liu YP; Yang Q; Zhang YN; Li JB; Li CF; Zou X; Yu T; Cao JY; Zhang MX; Jiang R; Sun R; Mo HY; Guo L; Cao KJ; Lin AH; Sun Y; Qian CN; Ma J; Chen MY
Theranostics; 2017; 7(8):2314-2324. PubMed ID: 28740554
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.
Yan M; Kumachev A; Siu LL; Chan KK
Eur J Cancer; 2015 Aug; 51(12):1570-9. PubMed ID: 26044925
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
Prawira A; Oosting SF; Chen TW; Delos Santos KA; Saluja R; Wang L; Siu LL; Chan KKW; Hansen AR
Br J Cancer; 2017 Dec; 117(12):1743-1752. PubMed ID: 29065104
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
